Name: Bazedoxifene acetate
Price: 220.00 USD

- Overview
  - Please contact us at for specific academic pricing.
    
    Background
    
    Bazedoxifene, a novel selective estrogen receptor modulator (SERM), has been developed to have favorable effects on bone and the lipid profile while minimizing stimulation of uterine or breast tissues. Two large Phase III clinical trials showed that Bazedoxifene, as well as raloxifene, increased bone mineral density, decreased levels of bone turnover markers, and significantly reduced the risk of new vertebral fractures in postmenopausal women compared with placebo.
- Properties
  - Categories
    
    Estrogen receptor modulator
    
    Alternative Name
    
    Viviant, WAY-140424, WAY-TES 424, Conbriza, TSE-424,; acetic acid;1-[[4-[2-(azepan-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methylindol-5-ol
    
    CAS Number
    
    198481-33-3
    
    Molecular Formula
    
    C32H38N2O5
    
    Molecular Weight
    
    530.65
    
    Appearance
    
    A solid
    
    Purity
    
    98.00%
    
    Solubility
    
    insoluble in H2O; ≥182 mg/mL in DMSO; ≥8.483 mg/mL in EtOH with gentle warming and ultrasonic
    
    Storage
    
    Store at -20°C
    
    SMILES
    
    CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O.CC(=O)O
    
    * For Research Use Only